Patent details

301362 Product Name: serplulimab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301362
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP4339615
Status:
SPC granted but not yet in force
Application number:
301362
Procedural language:
Dutch
First Applicant Residence Country:
China (CN)

Marketing Authorization

Marketing Authorization Number:
EU/1/24/1870/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
06/02/2025
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
19/01/2026
First Marketing Authorization date:
06/02/2025
Grant date:
10/02/2026
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
19/01/2026
SPC/SPC Extension Expiration Date:
05/02/2040
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
19/01/2026
 
 

 

Name:
Shanghai Henlius Biotech, Inc.
Address:
Room 303, 304, Block 7 No. 1999 Zhangheng Road Pilot Free Trade Zone, Shanghai, China (CN)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
19/01/2026
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
06/26
Publication date:
11/02/2026
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
03/26
Publication date:
21/01/2026
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
30/09/2037
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
10/02/2026 Outgoing Correspondence Decision grant 1 PDF /5/4/6/2/0/0801202645/docs/301362_6_301362695015l504a.pdf
10/02/2026 Outgoing Correspondence Decision grant 1 PDF /5/4/6/2/0/0801202645/docs/301362_7_301362695015l504a.pdf
10/02/2026 Certificate Certificate 1 PDF /5/4/6/2/0/0801202645/docs/301362_8_spcmedcertificate20260210082702993.pdf
20/01/2026 Outgoing Correspondence Confirmation receipt request 2 PDF /5/4/6/2/0/0801202645/docs/301362_0_301362691768l174.pdf
19/01/2026 Application Form First filed application form 2 PDF /5/4/6/2/0/0801202645/docs/301362_1_applicationform20260119042238732.pdf
19/01/2026 SPC Documents Annex SPC 4 PDF /5/4/6/2/0/0801202645/docs/301362_2_supplprotectioncertificate20260119042336915.pdf
19/01/2026 SPC Documents Annex SPC 1 PDF /5/4/6/2/0/0801202645/docs/301362_3_supplprotectioncertificate20260119042359397.pdf
19/01/2026 SPC Documents Summary of the characteristics of the product 23 PDF /5/4/6/2/0/0801202645/docs/301362_4_supplprotectioncertificate20260119042437582.pdf
19/01/2026 SPC Documents Marketing Authorization SPC 3 PDF /5/4/6/2/0/0801202645/docs/301362_5_supplprotectioncertificate20260119042500789.pdf